The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease
NCT00410007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2018-03-20
Summary
The aim of the study is to test the following hypotheses:
1. that the function and/or regulation of AQP2 and /or ENaC in the principal cells is abnormal in autosomal dominant polycystic kidney disease.
2. if an abnormal function of the principal cells is present in autosomal dominant polycystic kidney disease, this will become more pronounced at high and low sodium intake.
Conditions
- Polycystic Kidney, Autosomal Dominant
Interventions
- BEHAVIORAL
-
High Sodium Diet
250-350 mmol
- BEHAVIORAL
-
Low Sodium Diet
25-35 mmol
- BEHAVIORAL
-
Hypertonic saline infusion
7 ml/ kg of 3% saline were given over 30 minutes.
Sponsors & Collaborators
-
Carolina Cannillo
lead OTHER
Principal Investigators
-
Erling B. Pedersen, Professor · Department of Medical Research, Holstebro Hospital, Denmark
-
Carolina C. Graffe, MD · Department of Medical Research, Holstebro Hospital, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2010-10-31
- Completion
- 2011-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00890279 ·Status: UNKNOWN ·Phase: PHASE2
-
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
NCT00240656 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
NCT01407900 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)
NCT02523001 ·Status: COMPLETED
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
The Effect of Thiazide, Amiloride and Hypertonic Saline on Urinary Biomarkers in Healthy Subjects
NCT01635231 ·Status: COMPLETED ·Phase: NA
-
Effects of Somatostatin on ADPKD Heart
NCT02119013 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD
NCT03803124 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)
NCT02078973 ·Status: COMPLETED ·Phase: PHASE2
-
Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study
NCT00309283 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnosing Variable Primary Aldosteronism.
NCT05765786 ·Status: RECRUITING
-
Multi-omics Studies of Primary Aldosteronism
NCT07111351 ·Status: RECRUITING
-
A Study of CIN-107 in Adults With Primary Aldosteronism
NCT04605549 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01336972 ·Status: COMPLETED ·Phase: PHASE2
-
Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
NCT01918488 ·Status: UNKNOWN ·Phase: NA
-
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
NCT02040441 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT01414088 ·Status: COMPLETED ·Phase: NA
-
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 ·Status: UNKNOWN
-
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease
NCT03102632 ·Status: COMPLETED ·Phase: NA
-
Sodium Lowering and Urinary Protein Reduction Trial
NCT02945969 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure
NCT00843154 ·Status: TERMINATED ·Phase: PHASE3
-
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
NCT01056848 ·Status: COMPLETED
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Thyroid Hormones in ADPKD
NCT05646420 ·Status: COMPLETED ·Phase: NA